OTCPK:TLPPF (Australia)
Â
Ordinary Shares
$
18.22
+0.17 (+0.91%)
11:09 AM EST
New Key Statistics Module, Z-Score and F-Score
OTCPK:TLPPF Key Ratios
Market Cap $ M | 5,990.25 |
Enterprise Value $ M | 5,855.69 |
P/E(ttm) | 193.83 |
PE Ratio without NRI | 193.83 |
Forward PE Ratio | 56.93 |
Price/Book | 16.87 |
Price/Sales | 12.67 |
Price/Free Cash Flow | 1,063.70 |
Price/Owner Earnings | 237.36 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 507.00 |
EPS (TTM) $ | 0.09 |
Beneish M-Score | -1.84 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | 425.50 |
EV-to-EBIT | 97.69 |
EV-to-EBITDA | 97.69 |
PEG | -- |
Shares Outstanding M | 334.72 |
Net Margin (%) | 6.37 |
Operating Margin % | 10.40 |
Pre-tax Margin (%) | 7.16 |
Quick Ratio | 2.66 |
Current Ratio | 2.78 |
ROA % (ttm) | 5.61 |
ROE % (ttm) | 13.36 |
ROIC % (ttm) | 13.25 |
Dividend Yield % | -- |
Altman Z-Score | 7.01 |
TLPPF Number of Guru Trades
TLPPF Volume of Guru Trades
Gurus Latest Trades with OTCPK:TLPPF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:TLPPF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Telix Pharmaceuticals Ltd Insider Transactions
No Available Data
News about OTCPK:TLPPF
Total 0- 1